Glenn S. Tillotson

Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activity.

G. Tillotson, A. Dalhoff, C. Krasemann, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.

L. Mandell, G. Tillotson, G. Patou, 2004, International journal of antimicrobial agents.

Therapeutic advances of new fluoroquinolones.

G. Tillotson, P. Ball, A. Fernald, 1998, Expert opinion on investigational drugs.

Safety of fluoroquinolones: An update.

L. Mandell, G. Tillotson, L Mandell, 2002, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Formula to help select rational antimicrobial therapy (FRAT): its application to community- and hospital-acquired urinary tract infections.

Glenn S. Tillotson, J. M. Blondeau, 1999, International journal of antimicrobial agents.